Incassia Tablet
Product Images NDC 65862-925

4 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Incassia (NDC 65862-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Norethindrone Administration (Norethindrone Fig1)

Figure 1: Mean ± Sd Norethindrone Plasma Concentrations Following Norethindrone Administration (Norethindrone Fig1)
A line graph titled 'Mean ± SD Norethindrone Plasma Concentrations Following Incassia Administration' showing plasma concentration (Cp ng/mL) on the y-axis and time in hours on the x-axis. The plot presents concentration data for oral Incassia 0.35 mg over 48 hours, illustrating a rapid decline in plasma concentration over time with error bars representing standard deviation.*
FDA Label Image

Blister Pack (Norethindrone Fig2)

Blister Pack (Norethindrone Fig2)
An instructional diagram showing a hand placing a day label strip onto a pill packaging card. The label strip includes the days of the week (SUN, MON, TUE, WED, THU, FRI, SAT) to align with the pill doses, assisting users in tracking daily medication intake.*
FDA Label Image

Norethindrone-fig3 (Norethindrone Fig3)

Norethindrone-fig3 (Norethindrone Fig3)
Packaging label for Incassia (Norethindrone Tablets USP) 0.35 mg oral tablets by Aurobindo Pharma Limited. The label notes the product is a prescription drug with 3 blister packs containing 28 tablets each. It includes storage instructions, a note to the pharmacist on the patient labeling, and a warning that the product does not protect against HIV or other sexually transmitted diseases. The product is made in India, with barcodes and the NDC 65862-925-85 shown.*
FDA Label Image

Chemical Structure (Norethindrone Str)

Chemical Structure (Norethindrone Str)
Chemical structure of norethindrone, labeled with its therapeutic class as oral contraceptive. The diagram shows the molecular structure with labeled functional groups and bonds relevant to norethindrone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.